AIDS Therapies

AIDS Drug Assistance Programs Adopt Sustiva

Published in AIDS Weekly, March 29th, 1999

DuPont Pharmaceuticals, Wilmington, Delaware, announced that Pennsylvania and Texas have added Sustiva (efavirenz), the first once-daily anti-HIV treatment, to their state assistance program drug formularies, bringing the total to 48 U.S. states that have included the drug on such formularies.

Sustiva is on all state Medicaid formularies, as well.

"This acceptance of Sustiva by both Pennsylvania and Texas is good news for the underinsured and uninsured living with HIV and AIDS in those states," said Nicholas L. Teti, President, DuPont Pharmaceuticals.

Sustiva was added to the Pennsylvania Special Pharmaceutical Benefits Program...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1999-03-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry